Interstitial fluid (ISF) can be transdermally extracted using low-frequency ultrasound and continuous vacuum pressure
on skin surface. But the tiny volume of transdermally extracted ISF makes the transdermal extraction, collection,
transport, volumetric detection and glucose concentration measurement of the ISF very difficult. Based on a microfluidic chip for transdermally extraction of interstitial fluid and a micro glucose sensor for glucose concentration measurement, a continuous glucose monitoring instrumentby ISF transdermal extraction with minimally invasive way is developed. In the paper, various parts of the device and their interface circuits are designed; the hardware and software of the instrument are built; the simulating experiments of transdermal ISF extraction, collection and volume measurement with full-thickness pig skin are performed using this integrated system; and the functionalities of this device is verified for future clinical application.
In recent years, using the detection of interstitial fluid glucose concentration to realize the real-time continuous
monitoring of blood glucose concentration gets more and more attention, because for one person, the relationship
between blood glucose concentration and interstitial fluid glucose concentration satisfies specific rules. However, the
glucose concentration in interstitial fluid is not entirely equal to the glucose concentration in blood and has a
physiological lag because of the physiological difference of cells in blood and interstitial fluid. Because the clinical
diagnostic criteria of diabetes are still blood glucose concentration, the evaluation model of the physiological lag
parameter between the glucose concentration in blood and the glucose concentration in interstitial fluid should be
established. The physiological difference in glucose molecules uptake, utilization, and elimination by cells in blood and
interstitial fluid and the diffusion velocity of glucose molecule from blood to interstitial fluid will be induced to the mass
transfer model to express the physiological lag parameter. Based on the continuous monitoring of glucose concentration
in interstitial fluid, the project had studied the mass transfer model to establish the evaluation model of the physiological
lag parameter between the glucose concentration in blood and the glucose concentration in interstitial fluid. We have
preliminary achieved to evaluate the physiological lag parameter exactly and predict the glucose concentration in blood
through the glucose concentration in interstitial fluid accurately.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.